<DOC>
	<DOCNO>NCT02526771</DOCNO>
	<brief_summary>The aim study compare surgical outcome conventional lymph node dissection unconventional lymph node dissection resection Intrahepatic cholangiocarcinoma .</brief_summary>
	<brief_title>Conventional Unconventional Lymph Node Dissection During Resection Intrahepatic Cholangiocarcinoma</brief_title>
	<detailed_description>Intrahepatic cholangiocarcinoma ( ICC ) one primary liver cancer , high malignant , difficult treatment bad prognosis compare hepatocellular carcinoma incidence continue rise . The main radical treatment surgical resection , however , postoperative recurrence rate extremely high . The 3-year recurrence rate 50 % . It report lymph node metastasis rate ICC high 20 % 65 % , significant factor poor prognosis . The probability lymph node metastasis 13 % lymph node metastasis find preoperative intraoperative . It highly controversial whether undergo conventional lymph node dissection lymph node metastasis find preoperative intraoperative . A number researcher approve lymph node dissection situation . However , author Kim suggest lymph node resection necessary . Others Yang think consider different condition . Clark CJ think evidence dissection lymph node insufficient view reason , investigator plan implement randomize control study confirm prognostic value conventional unconventional lymph node dissection resection Intrahepatic cholangiocarcinoma .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<criteria>Male female patient &gt; 18 year &lt; =70 year age . Diagnosis intrahepatic cholangiocarcinoma ( image , serology , intraoperative frozen , etc . ) No lymph node metastasis preoperatively intraoperatively . Tumors completely resect . Criteria liver function : Child AB level , serum bilirubin ≤ 1.5 time upper limit normal value , alanine aminotransferase aspartate aminotransferase ≤ 2 time upper limit normal value . Patients understand trial sign information consent . Exclusion Criteria : Lymph node metastasis preoperatively . Tumors resect . Patients apparent cardiac , pulmonary , cerebral renal dysfunction , may affect treatment Intrahepatic cholangiocarcinoma . Patients medical history malignant tumor . Subjects participate clinical trial . liver function : Child C .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>lymph node dissection</keyword>
</DOC>